ZA201602375B - Polysaccharide-protein conjugates with enhanced immunogenicity and rapid high yielding process of preparation thereof - Google Patents

Polysaccharide-protein conjugates with enhanced immunogenicity and rapid high yielding process of preparation thereof

Info

Publication number
ZA201602375B
ZA201602375B ZA2016/02375A ZA201602375A ZA201602375B ZA 201602375 B ZA201602375 B ZA 201602375B ZA 2016/02375 A ZA2016/02375 A ZA 2016/02375A ZA 201602375 A ZA201602375 A ZA 201602375A ZA 201602375 B ZA201602375 B ZA 201602375B
Authority
ZA
South Africa
Prior art keywords
polysaccharide
preparation
protein conjugates
high yielding
rapid high
Prior art date
Application number
ZA2016/02375A
Inventor
Vibhu Kanchan
Deepti Singh
Juned Dalal
Rakesh Rana
Manoj Kumar Chhikara
Davinder Gill
Original Assignee
Msd Wellcome Trust Hilleman Laboratories Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN3047DE2013 external-priority patent/IN2013DE03047A/en
Application filed by Msd Wellcome Trust Hilleman Laboratories Pvt Ltd filed Critical Msd Wellcome Trust Hilleman Laboratories Pvt Ltd
Publication of ZA201602375B publication Critical patent/ZA201602375B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Sustainable Development (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA2016/02375A 2013-10-11 2016-04-08 Polysaccharide-protein conjugates with enhanced immunogenicity and rapid high yielding process of preparation thereof ZA201602375B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2363DE2014 2014-08-20
IN3047DE2013 IN2013DE03047A (en) 2013-10-11 2014-10-10
PCT/IB2014/065201 WO2015052684A2 (en) 2013-10-11 2014-10-10 Polysaccharide-protein conjugates with enhanced immunogenicity and rapid high yielding process thereof

Publications (1)

Publication Number Publication Date
ZA201602375B true ZA201602375B (en) 2017-07-26

Family

ID=52144766

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2016/02375A ZA201602375B (en) 2013-10-11 2016-04-08 Polysaccharide-protein conjugates with enhanced immunogenicity and rapid high yielding process of preparation thereof

Country Status (4)

Country Link
CN (1) CN105636608A (en)
MY (1) MY194920A (en)
WO (1) WO2015052684A2 (en)
ZA (1) ZA201602375B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105770890A (en) * 2016-03-08 2016-07-20 苏文全 Specific protein composition and application method thereof
CN106084037B (en) * 2016-06-08 2020-01-07 中国人民解放军第二军医大学 Bacillus anthracis capsule surface trisaccharide conjugate and preparation method and application thereof
CN109890413B (en) 2016-09-02 2024-04-16 赛诺菲巴斯德股份有限公司 Neisseria meningitidis vaccine
US11027005B2 (en) * 2016-10-20 2021-06-08 Km Biologics Co., Ltd. Method for producing Hib conjugate vaccine using PRP with lowered molecular weight
CN114965784B (en) * 2022-06-01 2023-10-27 艾美探索者生命科学研发有限公司 Method for measuring polysaccharide activation degree

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE254475T1 (en) * 1993-09-22 2003-12-15 Jackson H M Found Military Med METHOD FOR ACTIVATION OF SOLUBLE CARBOHYDRATES BY USING NEW CYANYLATION REAGENTS TO PRODUCE IMMUNOGENIC CONSTRUCTS
US8048432B2 (en) * 2003-08-06 2011-11-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Polysaccharide-protein conjugate vaccines
GB201103836D0 (en) * 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process

Also Published As

Publication number Publication date
MY194920A (en) 2022-12-23
CN105636608A (en) 2016-06-01
WO2015052684A2 (en) 2015-04-16
WO2015052684A3 (en) 2015-07-23

Similar Documents

Publication Publication Date Title
IL294622B1 (en) Antibody-drug conjugates and methods of producing same
IL267618B (en) Methods for producing antibody-drug conjugates
IL244254A0 (en) Engineered anti-dll3 conjugates and methods of use
IL244665A0 (en) Chlorotoxin conjugates and methods of use thereof
HK1218928A1 (en) Cancer vaccines and vaccination methods
ME03394B (en) Antidll3-antibody-pbd conjugates and uses thereof
HK1211224A1 (en) Multivalent glycoconjugate vaccines
GB201520943D0 (en) Novel linker and preparation method thereof
IL286759A (en) Therapeutic methods and compositions
ZA201602375B (en) Polysaccharide-protein conjugates with enhanced immunogenicity and rapid high yielding process of preparation thereof
GB201301085D0 (en) Glycoconjugate Vaccine
ZA201806043B (en) Novel polysaccharide-protein conjugates and process to obtain thereof
SG11201602258WA (en) Slow-release conjugates of sn-38
IL240031A0 (en) Hard-ballistic article and process to manufacture said article
HK1213800A1 (en) Toxoid, compositions and related methods
IL242584B (en) Immunogenic composition for use in therapy
IL245437A0 (en) Anti-efna4 antibodies and antibody-drug conjugates
HK1213917A1 (en) Toxoid, compositions and related methods
HUE050547T2 (en) Oligosaccharide conjugates and methods of use
HK1219109A1 (en) Immunogenic compositions and a process for producing same
GB201411724D0 (en) Improvements to packaging means and manufacture thereof
AU2013901875A0 (en) Immunogenic vaccines and uses thereof
GB201306706D0 (en) Novel process for preparation of antibody conjugates and novel antibody conjugates
GB201310472D0 (en) Antibody-drug conjugates
GB201319255D0 (en) Therapeutic compositions and methods